A detailed history of Eaton Vance Management transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Eaton Vance Management holds 561,500 shares of TNDM stock, worth $23.8 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
561,500
Previous 696,966 19.44%
Holding current value
$23.8 Million
Previous $41.3 Million 34.87%
% of portfolio
0.04%
Previous 0.06%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$43.76 - $68.97 $5.93 Million - $9.34 Million
-135,466 Reduced 19.44%
561,500 $26.9 Million
Q2 2022

Aug 15, 2022

BUY
$53.22 - $123.09 $21.7 Million - $50.1 Million
407,148 Added 140.48%
696,966 $41.3 Million
Q1 2022

May 16, 2022

BUY
$101.89 - $150.09 $2.71 Million - $3.99 Million
26,569 Added 10.09%
289,818 $33.7 Million
Q4 2021

Feb 14, 2022

SELL
$118.18 - $153.21 $20.8 Million - $26.9 Million
-175,781 Reduced 40.04%
263,249 $39.6 Million
Q3 2021

Nov 15, 2021

SELL
$93.51 - $129.4 $8.28 Million - $11.5 Million
-88,553 Reduced 16.78%
439,030 $52.4 Million
Q2 2021

Aug 16, 2021

BUY
$77.0 - $100.19 $5.43 Million - $7.07 Million
70,583 Added 15.44%
527,583 $51.4 Million
Q1 2021

May 17, 2021

BUY
$81.28 - $104.34 $9.3 Million - $11.9 Million
114,474 Added 33.42%
457,000 $40.3 Million
Q4 2020

Feb 12, 2021

BUY
$86.4 - $121.75 $5.49 Million - $7.73 Million
63,496 Added 22.76%
342,526 $32.8 Million
Q3 2020

Nov 13, 2020

BUY
$95.43 - $116.09 $2.17 Million - $2.64 Million
22,735 Added 8.87%
279,030 $31.7 Million
Q2 2020

Nov 20, 2020

BUY
$60.05 - $98.92 $9,668 - $15,926
161 Added 0.06%
256,295 $25.4 Million
Q2 2020

Aug 13, 2020

BUY
$60.05 - $98.92 $15.4 Million - $25.3 Million
256,134 New
256,134 $25.3 Million

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.72B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Eaton Vance Management Portfolio

Follow Eaton Vance Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.